Development of a new decellularization protocol for the whole porcine heart.
heart
porcine
protocol
scaffold
tissue engineering
Journal
Journal of clinical and translational research
ISSN: 2424-810X
Titre abrégé: J Clin Transl Res
Pays: Singapore
ID NLM: 101667205
Informations de publication
Date de publication:
26 Aug 2021
26 Aug 2021
Historique:
received:
09
02
2021
revised:
22
06
2021
accepted:
20
07
2021
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
21
9
2021
Statut:
epublish
Résumé
Cardiovascular diseases are the leading cause of death in many countries. Advances in technology have been promoted in this regard, especially in tissue engineering, to meet the need for tissue or organ grafts. In this way, the porcine model has been used due to its morphophysiological similarity between the human species, mainly regarding the cardiovascular system. Tissue engineering is employed using biological scaffolds that are currently derived from porcine. These scaffolds are produced by decellularization, a process to remove cells aiming to maintain only its three-dimensional structure, formed by extracellular matrix (ECM). Its main objective is to produce organs through recellularized scaffolds that could eventually substitute the ones with impaired functions. In this way, the present study aimed to establish a new protocol for porcine heart decellularization with potential application on tissue engineering. A porcine heart aorta was cannulated with a silicon tube, and the organ was washed in 0.1% phosphate-buffered saline through a peristaltic pump (Harvard Peristaltic Pump - Harvard Apparatus). After that, deionized water was introduced in the same system. The decellularization procedure was carried out using ionic and non-ionic detergents, namely 4% sodium dodecyl sulfate (SDS) and 1% Triton X-100, respectively. SDS was perfused through myocardial circulation at 400 mL/min for 24 h for 6 days. Subsequently, the heart was infused with Triton X-100 and washed by PBS and water for 24 h. The heart volume was measured before and after the recellularization. After macroscopic evaluation, the heart samples were processed and stained by Hematoxylin and Eosin, Masson's Trichrome, Weigert-Van Gieson, Alcian Blue, and Pricrosirius Red techniques for microscopic analysis. To observe the cell adhesion, the recellularization was provided in this scaffold, which was analyzed under immunofluorescence and scanning electronic microscopy. The protocol provided cells remotion, with adequate concentration of remaining DNA. ECM components as collagen type I, elastin, and glycosaminoglycans were successfully maintained. The scaffold showed a high cells adherence and proliferation in the recellularization process. According to results, the protocol described in this work preserved the ECM components and the organ architecture, minimizing ECM loss and being possible to state that it is a promising approach to tissue bioengineering. This study provides a protocol for whole porcine heart decellularization, which will ultimately contribute to heart bioengineering and may support further studies on biocompatibility relationship of new cells with recellularized scaffolds.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiovascular diseases are the leading cause of death in many countries. Advances in technology have been promoted in this regard, especially in tissue engineering, to meet the need for tissue or organ grafts. In this way, the porcine model has been used due to its morphophysiological similarity between the human species, mainly regarding the cardiovascular system. Tissue engineering is employed using biological scaffolds that are currently derived from porcine. These scaffolds are produced by decellularization, a process to remove cells aiming to maintain only its three-dimensional structure, formed by extracellular matrix (ECM). Its main objective is to produce organs through recellularized scaffolds that could eventually substitute the ones with impaired functions.
AIM
OBJECTIVE
In this way, the present study aimed to establish a new protocol for porcine heart decellularization with potential application on tissue engineering.
METHODS
METHODS
A porcine heart aorta was cannulated with a silicon tube, and the organ was washed in 0.1% phosphate-buffered saline through a peristaltic pump (Harvard Peristaltic Pump - Harvard Apparatus). After that, deionized water was introduced in the same system. The decellularization procedure was carried out using ionic and non-ionic detergents, namely 4% sodium dodecyl sulfate (SDS) and 1% Triton X-100, respectively. SDS was perfused through myocardial circulation at 400 mL/min for 24 h for 6 days. Subsequently, the heart was infused with Triton X-100 and washed by PBS and water for 24 h. The heart volume was measured before and after the recellularization. After macroscopic evaluation, the heart samples were processed and stained by Hematoxylin and Eosin, Masson's Trichrome, Weigert-Van Gieson, Alcian Blue, and Pricrosirius Red techniques for microscopic analysis. To observe the cell adhesion, the recellularization was provided in this scaffold, which was analyzed under immunofluorescence and scanning electronic microscopy.
RESULTS
RESULTS
The protocol provided cells remotion, with adequate concentration of remaining DNA. ECM components as collagen type I, elastin, and glycosaminoglycans were successfully maintained. The scaffold showed a high cells adherence and proliferation in the recellularization process.
CONCLUSION
CONCLUSIONS
According to results, the protocol described in this work preserved the ECM components and the organ architecture, minimizing ECM loss and being possible to state that it is a promising approach to tissue bioengineering.
RELEVANCE FOR PATIENTS
UNASSIGNED
This study provides a protocol for whole porcine heart decellularization, which will ultimately contribute to heart bioengineering and may support further studies on biocompatibility relationship of new cells with recellularized scaffolds.
Identifiants
pubmed: 34541369
pii: jctres.07.202104.017
pmc: PMC8445630
Types de publication
Journal Article
Langues
eng
Pagination
563-574Informations de copyright
Copyright: © Whioce Publishing Pte. Ltd.
Déclaration de conflit d'intérêts
The authors state no competing interest.
Références
Ann Biomed Eng. 2016 Sep;44(9):2827-39
pubmed: 26842626
Transpl Int. 2019 Jun;32(6):571-585
pubmed: 31099920
Nat Med. 2008 Feb;14(2):213-21
pubmed: 18193059
J Biomed Mater Res A. 2019 Oct;107(10):2235-2243
pubmed: 31125175
J Clin Transl Res. 2017 Mar 15;3(2):260-270
pubmed: 30873477
J Cell Biochem. 2012 Jul;113(7):2217-22
pubmed: 22415903
Biomaterials. 2011 Apr;32(12):3233-43
pubmed: 21296410
Acta Biomater. 2017 Feb;49:181-191
pubmed: 27884776
Tissue Eng Part C Methods. 2015 Nov;21(11):1148-61
pubmed: 26077163
Xenotransplantation. 2020 May;27(3):e12609
pubmed: 32449225
Methods Cell Biol. 2020;157:3-21
pubmed: 32334718
PLoS One. 2014 Feb 27;9(2):e90406
pubmed: 24587354
J Biomed Mater Res B Appl Biomater. 2018 Feb;106(2):909-923
pubmed: 28194860
J Vis Exp. 2012 Dec 06;(70):e50059
pubmed: 23242494
Tissue Eng Part C Methods. 2010 Oct;16(5):1201-11
pubmed: 20170425
Methods. 2015 Aug;84:25-34
pubmed: 25791470
Methods Mol Biol. 2018;1577:95-102
pubmed: 28456953
Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):230-236
pubmed: 29155942
Tissue Eng Part C Methods. 2010 Jun;16(3):525-32
pubmed: 19702513
J Mater Sci Mater Med. 2016 Apr;27(4):70
pubmed: 26886818